Correlation between serum vitamin D levels and inflammation-related indicators in patients with atherosclerosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200056453

Enrollment

Unknown

Registered

2022-02-06

Start date

2022-02-10

Completion date

Unknown

Last updated

2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

IMT normal group:none

IMT thickening group:none

IMT plaque formation group:none

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. People with atherosclerosis or healthy people; 2. The patients and their families were informed and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Suffering from infectious or systemic inflammatory diseases; 2. Chronic diseases such as heart failure (left ventricular ejection fraction = 20 x 10^9/L); 4. Patients with abnormal thyroid function; 5. Patients with severe liver and kidney dysfunction (transaminase>2 times the upper limit of normal, creatinine>2.0mg/dL); 6. Patients with malignant tumors; 7. Those who have taken vitamin D and related products orally within 3 months.

Design outcomes

Primary

Measure	Time frame
Vitamin D;Inflammatory biomarkers;	—

Countries

China

Contacts

Public ContactAi Keqing

Nanjing First Hospital

keqing1209@163.com+86 15366179635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026